Community-dwelling mental health patients access to pharmacogenetics through community pharmacies as a tool for pharmacotherapeutic optimization: a research design in Barcelona, Catalonia, Spain.

• At: Seville (Spain) (2022)
• Type: Poster
• Poster code: PPR-035
• By: MIR BONNíN, Joan Francesc (Col·legi de Farmacèutics de Barcelona, Spain)
• Co-author(s): Dr Joan Francesc Mir Bonnín, Consultant Pharmacist And Researcher (Col·legi de Farmacèutics de Barcelona, Barcelona, Spain)
  Ms Cristina Rodríguez-Caba, Projects and Research Area (Col·legi de Farmacèutics de Barcelona, Barcelona, Spain)
  Ms Maria Estrada, Consultant Pharmacist (Col·legi de Farmacèutics de Barcelona, Barcelona, Spain)
  Dr Llanos Torres-Sánchez, Psychiatry (Centre de Salut Mental i Addiccions de Gràcia. Hospital Mare de Deu de la Mercè - Germanes Hospitalàries, Barcelona, Spain)
  Dr Cristina Teixidó Perramon, Psychiatry (CSM Dreta-Encants-Camp de l'Arpa - CPB Serveis Salut Mental, Barcelona, Spain)
  Mr Guillermo Bagaría, Community Pharmacists Provincial Spokesperson (Col·legi de Farmacèutics de Barcelona, Barcelona, Spain)
  Dr Pau Riera, Hospital Pharmacy Department - Genetics Department (Hospital de la Santa Creu i Sant Pau, Barcelona, Spain)
  
• Abstract:

  BACKGROUND Response to psychotropic drugs is highly variable: 20-30% patients have no response to antidepressants, whereas 30-50% patients treated with neuroleptics have side effects or no response to them. Many factors affect psychotropic response: age, sex, adherence, comorbidities and genetic baggage amongst others. Ineffectiveness, side..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login